C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
POSAF Equity

POSAF

OTCMKTS · POSAF

$0.06
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
46/100 composite
Fundamentals49
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

POSaBIT Systems (POSAF) has been rated as Neutral with a composite score of 46.1 and a conviction level of 2 out of 5. The score highlights a modest balance between its operational and market positioning amidst a stretched financial condition. A significant portion of the composite is drawn from its regulatory pillar, which scored notably higher than the other elements, reflecting the positive impact of its domicile in Canada’s favorable regulatory climate. The fundamentals pillar, although constrained by weak growth, offers some stability through strong gross margins.

POSaBIT faces challenges with its year-over-year revenue decline, compounded by negative operating margins, resulting in a net income loss and a negative EBITDA. The company's gross profit offers a silver lining, presenting an unusual contrast to the drops in income and highlighted by an enviable gross margin percentage. However, the lack of market visibility, indicated by the absence of available market quotations, restricts broader investment appeal. Although primary regulatory filings have stagnated without fresh updates in recent months, there has been no adverse regulatory action recorded during this period that could further destabilize the financial condition.

The strongest forward-looking signal is the regulatory environment. As the regulatory pillar holds the most weight in the composite efficacy, attention should center on any evolving legislation within Canada and potential market re-entry opportunities. Such developments could catalyze improved operational performance and enhance POSA BIT's appeal within the investment community. Stakeholders should closely monitor any updates from future regulatory filings and the adaptation of POSA BIT’s strategy to align with evolving legislation.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
Ryan Hamlin
CFO
Stephen Gledhill
SEC CIK
0001844459
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$8.1M
Enterprise value
$8.4M
Price to book
4.50
Price to sales
0.87
EV / EBITDA
-17.46
Revenue (TTM)
$9.3M
Gross profit (TTM)
$7.7M
EBITDA
$-1.2M
Operating margin
-10.3%
Profit margin
-12.5%
Rev growth YoY
-25.0%
Return on equity
-540.2%
Return on assets
-11.7%
Shares outstanding
162.2M
Insider ownership
34.4%
Beta
1.01
Full-time employees
35
GICS sector
Technology
GICS industry
Software - Application
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for POSAF (POSAF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for POSAF (POSAF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for POSAF are maintained by Cannabis Investor News and refreshed throughout the trading day.